(MedPage Today) — The first participant in an investigational gene therapy trial of STXBP1 encephalopathy died, Capsida Biotherapeutics said.
The death occurred days after dosing, according to information posted on the STXBP1 Foundation website…
Source link : https://www.medpagetoday.com/neurology/generalneurology/117425
Author :
Publish date : 2025-09-11 20:32:00
Copyright for syndicated content belongs to the linked Source.
